Enhancers predominantly regulate gene expression during differentiation via transcription initiation
- PMID: 33539786
- PMCID: PMC7612206
- DOI: 10.1016/j.molcel.2021.01.002
Enhancers predominantly regulate gene expression during differentiation via transcription initiation
Abstract
Gene transcription occurs via a cycle of linked events, including initiation, promoter-proximal pausing, and elongation of RNA polymerase II (Pol II). A key question is how transcriptional enhancers influence these events to control gene expression. Here, we present an approach that evaluates the level and change in promoter-proximal transcription (initiation and pausing) in the context of differential gene expression, genome-wide. This combinatorial approach shows that in primary cells, control of gene expression during differentiation is achieved predominantly via changes in transcription initiation rather than via release of Pol II pausing. Using genetically engineered mouse models, deleted for functionally validated enhancers of the α- and β-globin loci, we confirm that these elements regulate Pol II recruitment and/or initiation to modulate gene expression. Together, our data show that gene expression during differentiation is regulated predominantly at the level of initiation and that enhancers are key effectors of this process.
Keywords: Poll II recruitment; enhancers; gene regulation; promoter proximal pausing; transcription.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests J.R.H. is a founder and director of Nucleome Therapeutics.
Figures
Comment in
-
Enhancing initiation.Nat Rev Genet. 2021 Apr;22(4):201. doi: 10.1038/s41576-021-00339-7. Nat Rev Genet. 2021. PMID: 33623154 No abstract available.
References
-
- Bernecky C, Herzog F, Baumeister W, Plitzko JM, Cramer P. Structure of transcribing mammalian RNA polymerase II. Nature. 2016;529:551–554. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 107928/Z/15/Z/WT_/Wellcome Trust/United Kingdom
- MC_UU_00016/1/MRC_/Medical Research Council/United Kingdom
- MC_U137961145/MRC_/Medical Research Council/United Kingdom
- 106130/WT_/Wellcome Trust/United Kingdom
- 209181/WT_/Wellcome Trust/United Kingdom
- 106130/Z/14/Z/WT_/Wellcome Trust/United Kingdom
- MC_UU_00016/12/MRC_/Medical Research Council/United Kingdom
- MC_U137961144/MRC_/Medical Research Council/United Kingdom
- MC_UU_00016/4/MRC_/Medical Research Council/United Kingdom
- MR/T014067/1/MRC_/Medical Research Council/United Kingdom
- G1000801/MRC_/Medical Research Council/United Kingdom
- MC_UU_12009/4/MRC_/Medical Research Council/United Kingdom
- 209181/Z/17/Z/WT_/Wellcome Trust/United Kingdom
- 107928/WT_/Wellcome Trust/United Kingdom
- MC_UU_12009/15/MRC_/Medical Research Council/United Kingdom
- 339270/ERC_/European Research Council/International
- R37 DK044746/DK/NIDDK NIH HHS/United States
- MC_PC_15069/MRC_/Medical Research Council/United Kingdom
- MC_UU_12009/13/MRC_/Medical Research Council/United Kingdom
- MC_UU_00016/14/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
